期刊文献+

人白介素24单克隆抗体的制备与鉴定

Preparation and identification of monoclonal antibodies against interleukin 24
下载PDF
导出
摘要 目的:制备抗白细胞介素24(Interleukin 24,IL-24)的单克隆抗体并对其生物学特性进行鉴定。方法:应用分子生物学技术,构建含人IL-24编码序列的原核表达载体,表达并纯化了人IL-24融合蛋白。用纯化人IL-24融合蛋白免疫Balb/c小鼠,取其脾细胞与小鼠骨髓瘤细胞SP2/0进行融合,用间接ELISA方法筛选杂交瘤细胞,有限稀释法进行亚克隆,采用免疫印迹及免疫组化染色对抗体的特异性进行了鉴定。结果:获得3株能稳定分泌抗IL-24单抗的杂交瘤细胞,分别命名为1G2,3F4,4A6。通过免疫印迹及免疫组化染色检测显示,这3株单抗均能够与IL-24特异性结合。结论:成功制备抗IL-24单克隆抗体,为进一步探索IL-24在抗肿瘤中的作用机制奠定了基础。 Objective: To prepare and identify the monoclonal antibody against interleukin 24(IL-24).Methods: Prokaryotic expressing vector containing human IL-24 gene was constructed by molecular biology techniques.Then human IL-24 fusion protein was expressed and purified.Splenocytes from the Balb/c mice immunized by human IL-24 fusion protein were fused with myeloma cells SP2/0 for producing hybridoma.Hybridoma cell line secreting antibodies against human IL-24 was determined by indirect ELISA and limiting dilution assay.The specificity of monoclonal antibodies against human IL-24 were evaluated with Western blot and immunohistochemistry staining.Results: Three hybridoma cell lines stably secreting monoclonal antibodies against human IL-24 were developed and named 1G2,3F4 and 4A6 respectively.By Western blot and immunohistochemistry staining,the results indicated that all monoclonal antibodies raised could specifically react with human IL-24.Conclusion: The success in production of IL-24 monoclonal antibody provides a foundation for studying the function of IL-24 in anti-tumor experiments.
出处 《现代肿瘤医学》 CAS 2011年第9期1701-1705,共5页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:30872993) 陕西师范大学"优秀博士学位论文"(编号:X2008YB07)
关键词 白细胞介素24 原核表达 杂交瘤 单克隆抗体 interleukin 24 prokaryotic expression hybridoma monoclonal antibody
  • 相关文献

参考文献10

  • 1Los M.New,exciting developments in experimental therapies inthe early 21st century. European Journal of Pharmacology . 2009
  • 2Dent P,Yacoub A,Hamed H A,et al.MDA-7/IL-24 as acancer therapeutic:from bench to bedside. Anti Cancer Drugs . 2010
  • 3Dalloul A,Sainz-Perez A.Interleukin-24:a molecule withpotential anti-cancer activity and a cytokine in search of a func-tion. Endocr Metab Immune Disord Drug Targets . 2009
  • 4Emdad L,Lebedeva IV,Su ZZ,Gupta P,Sauane M,Dash R,et al.Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. Cancer Biology and Therapy . 2009
  • 5Eager R,Harle L,Nemunatis J.Ad-MDA-7;INGN241:Areview of preclinical and clinical experience. Expert Opinion on Biological Therapy . 2008
  • 6Anderson RD,Haskell RE,Xia H,et al.A simple method for the rapid generation of recombinant adenovirus vectors. Gene Therapy . 2000
  • 7Sauane M,Gupta P,Lebedeva IV,Su ZZ,Sarkar D,Randolph A,Valerie K,Gopalkrishnan RV,Fisher PB.N-glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and "bystander" antitumor activity. Cancer Research . 2006
  • 8Jiang H,Lin JJ,Su ZZ,et al.Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncegene . 1995
  • 9Caudell EG,Mumm JB,Poindexter N,et al.The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. Journal of Immunology . 2002
  • 10Gupta P,Su ZZ,Lebedeva IV,et al.Mda-7/IL-24:Multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacology and Therapeutics . 2006

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部